Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-01-27

FDA Approved: LAMOTRIGINE — Original Application (Jubilant Cadista Pharmacuticals Inc.)

View source ↗

Summary

FDA approved Jubilant Cadista Pharmaceuticals Inc.'s original ANDA for lamotrigine, establishing a generic lamotrigine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (generic) (Lamotrigine)

Snippet

ORIG AP for LAMOTRIGINE (LAMOTRIGINE)